A retrospective analysis of men with low to intermediate-risk PCa found that PSMA identified GG≥ 2 malignancies more frequently than GG 1 with sensitivity of 88% versus 18% [6]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.